Abstract

In a preceding work we have reported experiments showing that an hydroalcoholic exctract of Agaricus blazei is able to exert purinergic effects in the isolated perfused rat liver when it is infused into the portal vein in monovascular perfusion (entry: portal vein; exit: hepatic vein). In the present communication we are presenting and discussing experiments done with the bivascularly perfused rat liver (entry: portal vein + hepatic artery; exit: hepatic vein) in order to verify if the hemodynamic effects also occur in the arterial bed. It was found that the A. blazei extract is also active when infused into the hepatic arterial bed, with differences in both sensitivity and nature of the effects on either perfusion pressure or oxygen consumption. Constriction of the arterial bed required much higher concentrations of the extract than the portal bed. The kinetics of the response was also different, with a biphasic instead of a monophasic response. These results provide a promising starting point for future studies aiming to bring to light more mechanistic details about these and possibly other effects.

Highlights

  • In a preceding work we have reported experiments showing that a hydroalcoholic extract of Agaricus blazei is able to exert purinergic effects in the isolated perfused rat liver when it is infused into the portal vein [3]

  • In the first one the A. blazei extract was infused into the hepatic artery at a rate that ensures a concentration of 400 mg/liter in the arterial bed

  • In conclusion it can be said that the Agaricus blazei extract is active when infused into the hepatic arterial bed, with differences in both sensitivity and nature of the effects on either perfusion pressure or oxygen consumption

Read more

Summary

Introduction

In a preceding work we have reported experiments showing that a hydroalcoholic extract of Agaricus blazei is able to exert purinergic effects in the isolated perfused rat liver when it is infused into the portal vein [3]. For example, has several functions in the central nervous system ranging from inhibition of neurotransmission to neuroprotective actions under pathological conditions [5] [6]. These effects are mediated mainly by purinergic receptors, from which several types and subtypes were described [4]

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call